[go: up one dir, main page]

SK8062000A3 - A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine - Google Patents

A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine Download PDF

Info

Publication number
SK8062000A3
SK8062000A3 SK806-2000A SK8062000A SK8062000A3 SK 8062000 A3 SK8062000 A3 SK 8062000A3 SK 8062000 A SK8062000 A SK 8062000A SK 8062000 A3 SK8062000 A3 SK 8062000A3
Authority
SK
Slovakia
Prior art keywords
ethyl
amine
propoxyphenoxy
isopropylmethyl
phosphoric acid
Prior art date
Application number
SK806-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Karol Horvath
Ulf Larsson
Rune Sandberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK8062000A3 publication Critical patent/SK8062000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK806-2000A 1997-12-22 1998-12-15 A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine SK8062000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704835A SE9704835D0 (sv) 1997-12-22 1997-12-22 New compound
PCT/SE1998/002316 WO1999032431A1 (fr) 1997-12-22 1998-12-15 Nouveau phosphate d'isopropylmethyl-[2-(3-n-propoxyphenoxy)ethyl]amine

Publications (1)

Publication Number Publication Date
SK8062000A3 true SK8062000A3 (en) 2001-02-12

Family

ID=20409538

Family Applications (1)

Application Number Title Priority Date Filing Date
SK806-2000A SK8062000A3 (en) 1997-12-22 1998-12-15 A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine

Country Status (22)

Country Link
US (1) US6235792B1 (fr)
EP (1) EP1047663A1 (fr)
JP (1) JP2001526254A (fr)
KR (1) KR20010033407A (fr)
CN (1) CN1280559A (fr)
AR (1) AR017199A1 (fr)
AU (1) AU1989299A (fr)
BR (1) BR9814381A (fr)
CA (1) CA2314989A1 (fr)
EE (1) EE200000384A (fr)
HU (1) HUP0004428A3 (fr)
ID (1) ID26940A (fr)
IL (1) IL136829A0 (fr)
IS (1) IS5544A (fr)
NO (1) NO20003216L (fr)
PL (1) PL341525A1 (fr)
SE (1) SE9704835D0 (fr)
SK (1) SK8062000A3 (fr)
TR (1) TR200002012T2 (fr)
TW (1) TW455590B (fr)
WO (1) WO1999032431A1 (fr)
ZA (1) ZA9811237B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
AR004691A1 (es) * 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
AU1989299A (en) 1999-07-12
EP1047663A1 (fr) 2000-11-02
KR20010033407A (ko) 2001-04-25
NO20003216D0 (no) 2000-06-21
WO1999032431A1 (fr) 1999-07-01
AR017199A1 (es) 2001-08-22
TR200002012T2 (tr) 2000-10-23
CA2314989A1 (fr) 1999-07-01
US6235792B1 (en) 2001-05-22
TW455590B (en) 2001-09-21
ZA9811237B (en) 1999-07-19
NO20003216L (no) 2000-06-21
IL136829A0 (en) 2001-06-14
EE200000384A (et) 2001-12-17
PL341525A1 (en) 2001-04-23
JP2001526254A (ja) 2001-12-18
SE9704835D0 (sv) 1997-12-22
HUP0004428A2 (hu) 2002-03-28
HUP0004428A3 (en) 2002-04-29
ID26940A (id) 2001-02-22
BR9814381A (pt) 2000-10-10
CN1280559A (zh) 2001-01-17
IS5544A (is) 2000-06-21

Similar Documents

Publication Publication Date Title
KR960016119B1 (ko) 히드록시메틸기 및 치환된 페닐기에 의해 치환된 신규의 이미다졸리딘, 이들의 제조방법, 의약으로서 이들의 용도, 이들을 함유하는 제약조성물 및 이들의 제조를 위한 중간체
US6559314B2 (en) Method for the production of thiazolidin
EP0104342B1 (fr) Acides triphénylimidazolyloxyalcanoiques et leurs dérivés, procédé de leur préparation et compositions pharmaceutiques les contenant
JP2738946B2 (ja) ジデオキシジデヒドロ炭素環式ヌクレオシド
GB2158440A (en) 4,5,6,7-Tetrahydroimidazo[4,5-c]pyridine derivatives
US5545654A (en) Pleuromutilin derivatives
US4866056A (en) Benzazepines and methods therefor
US4213995A (en) 2-Phenylimino-imidazolidines and salts thereof
EP0559625B1 (fr) Esters de L-carnitine et acyl-L-carnitine dotés d'une activité relaxante des muscles, sélective dans le tractus gastro-intestinel et compositions pharmaceutiques les contenant
EP0220653B1 (fr) Dérivés de l'acide 3-aminocarbonyl-1,4-dihydropyridine-5-carboxylique, leur procédé de préparation, leur application et les compositions pharmaceutiques les contenant
US6235792B1 (en) Phosphate salt of isopropyl-methyl- [2-(3-n-propoxyphenoxy)ethyl]amine
EP0332064A2 (fr) Dérivés du benzocycloheptène, médicament contenant ces composés et procédé de leur préparation
KR100264185B1 (ko) 프로테인 키나아제가 매개하는 질병의 치료와 예방을 위한 신규한 아제판과 그 고리 동족체들
MXPA00006128A (en) A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL-[2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE
FI57589B (fi) Foerfarande foer framstaellning av blodtrycket saenkande 6-substituerade 3-karbetoksihydrazinopyridaziner
GB2211185A (en) Uridine derivatives and antiviral agents containing them
SU1456016A3 (ru) Способ получени имидазолсодержащих соединений или их кислотно-аддитивных солей
CZ20002312A3 (cs) Nová fosfátová sůl izopropylmethyl-[2-(3-npropoxyfenoxy)ethyl]aminu
CS221527B2 (en) Method of preparation of n-/1-methyl-2-pyrrolidinylmethyl/2,3-dimethoxy-5-methylsulphamoylbenzamide
US5698580A (en) Antiviral agent containing benzodithiin derivative as active ingredient
EP0240986A2 (fr) Dérivés de D-Nor-7-ergoline, procédé pour leur préparation, composition pharmaceutique et utilisation
EP0003265B1 (fr) Dérivés d'imidazole ayant une activité immuno-stimulatrice, leur préparation et leurs compositions pharmaceutiques
EP0682023B1 (fr) Dérivés d'imidazopyridine et procédé pour leur préparation
SK279253B6 (sk) Vo vode vysoko rozpustné, stabilné a kryštalické s
EP0266711A1 (fr) 2,6-Diamino-3-halobenzyl-pyridines et procédé pour leur préparation ainsi que leur utilisation dans des agents pharmaceutiques